PHARMA BALTICA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 43 | - | - | 470 | 1,630 | 13,679 | 18,719 | 12,747 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -917 | -752 | -175 | 791 | 1,924 | -1,203 | 8,600 | 4,179 |
| Equity | -79,624 | -80,376 | -80,551 | -79,760 | -77,836 | -79,039 | -70,439 | -66,260 |
| Liabilities | 80,670 | 81,539 | 81,765 | 83,900 | 80,371 | 81,892 | 79,302 | 80,433 |
| Non-current assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 760 |
| Current assets | 1,328 | 1,486 | 1,537 | 4,463 | 2,858 | 2,774 | 8,783 | 13,413 |
| Total assets | 1,329 | 1,487 | 1,538 | 4,464 | 2,859 | 2,775 | 8,784 | 14,173 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 91 | 372 | 4 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | +246.8% | +739.2% | +36.8% | -31.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -69.0% | -50.6% | -11.4% | 17.7% | 67.3% | -43.4% | 97.9% | 29.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -2132.6% | - | - | 168.3% | 118.0% | -8.8% | 45.9% | 32.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 22 | - | - | 235 | 815 | 6,840 | 9,360 | 6,374 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
PHARMA BALTICA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-09-16 | 2022-09-19 | 151.10 |
PHARMA BALTICA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
PHARMA BALTICA, UAB (code 111445675) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, revenue amounted to €12.7K, down 31.9% year on year, while net profit was €4.2K. The company remained profitable, with a profit margin of 32.8%, although this followed a much stronger 2024, when revenue reached €18.7K and net profit was €8.6K. In 2023, the business generated €13.7K in revenue and recorded a net loss of €1.2K, showing an overall shift from loss to profit over the three-year period. The balance sheet remains highly leveraged, with total assets of €14.2K, equity of -€66.3K and liabilities of €80.4K at the end of 2025. Asset turnover was 0.90x, indicating revenue generation from a relatively small asset base. Productivity indicators show revenue per employee of €6.4K and profit per employee of €2.1K. Profitability ratios linked to equity should be interpreted cautiously because equity remained negative in 2025.